Table 3.
miRNA name | log 2(FI/FU) a | log 2(MI/MU) a | Target Gene id | log 2(FI/FU) b | log 2(MI/MU) b | Gene description | Pathway c |
---|---|---|---|---|---|---|---|
novel_126 | -9.6029 | -4.9958 | tetur13g00510 | 2.7968 | -- | Histone H2B (Fragments) | |
novel_32 | -7.6988 | -4.1657 | tetur19g00840 | 2.7184 | 2.688 | -//- | |
novel_23 | -4.8914 | 2.8724 | tetur19g00830 | 2.9756 | -- | Tetratricopeptide repeat protein 19, mitochondrial | |
tetur10g01260 | -- | -3.5643 | Retrovirus-related Pol polyprotein from transposon 412 | ||||
novel_105 | -4.8984 | -4.8537 | tetur01g12840 | 1.9333 | -- | Adult-specific rigid cuticular protein 15.7 | |
tetur11g00600 | 1.1574 | -- | Cuticle protein 10.9 | ||||
novel_36 | -4.4893 | -3.5605 | tetur11g00940 | 6.2399 | -- | Meiosis arrest female protein 1 | |
novel_16 | -4.1131 | -5.6105 | tetur09g06680 | 4.1748 | 2.2697 | Glucosylceramidase | YES |
tetur26g00300 | 4.047 | 4.5209 | Protein lifeguard 1 | ||||
novel_89 | -3.5904 | -4.4674 | tetur19g00830 | 2.9756 | 4.0633 | Tetratricopeptide repeat protein 19, mitochondrial | |
novel_109 | -1.9278 | -3.8031 | tetur04g01490 | 2.5622 | -- | -//- | |
tetur09g04610 | -- | 1.0918 | Multidrug resistance-associated protein 1 | ||||
novel_43 | -1.1435 | -2.2486 | tetur03g00110 | 2.9146 | -- | Protein lethal (2) essential for life | YES |
tetur04g01580 | 1.9481 | -- | -//- | ||||
tetur28g01280 | 2.3157 | -- | Beta-1,3-galactosyltransferase sqv-2 | YES | |||
tetur87g00010 | 2.5029 | -- | Nuclear hormone receptor HR96 | ||||
tetur09g04610 | -- | 1.0918 | Multidrug resistance-associated protein 1 | ||||
tur-miR-12b-5p | 1.2635 | 1.1341 | tetur06g06620 | -2.1594 | -- | -//- | |
tetur26g00570 | -8.9015 | -- | Low-density lipoprotein receptor-related protein 8 | ||||
novel_33 | 1.4415 | 2.8724 | -- | ||||
tur-miR-317-5p | 1.5433 | 1.2203 | -- | ||||
tur-miR-745-3p | 1.6556 | 2.0244 | -- |
aThe columns two and three show the log2 (fold-change) of miRNAs; bThe columns five and six show the log2 (fold-change) of mRNAs. cThree target genes have been enriched in the KEGG pathways.